Page last updated: 2024-11-01

nomifensine and Allodynia

nomifensine has been researched along with Allodynia in 2 studies

Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Martins, I1
de Vries, MG1
Teixeira-Pinto, A1
Fadel, J1
Wilson, SP1
Westerink, BH1
Tavares, I1
Gonzalez, JP1
Sewell, RD1
Spencer, PS1

Other Studies

2 other studies available for nomifensine and Allodynia

ArticleYear
Noradrenaline increases pain facilitation from the brain during inflammatory pain.
    Neuropharmacology, 2013, Volume: 71

    Topics: Adrenergic Neurons; Animals; Behavior, Animal; Disease Models, Animal; Encephalitis; Gene Knockdown

2013
Dopaminergic involvement in the hyperalgesic effect of nomifensine.
    Life sciences, 1981, Feb-23, Volume: 28, Issue:8

    Topics: Animals; Dopamine; Dose-Response Relationship, Drug; Haloperidol; Hot Temperature; Hyperalgesia; Hyp

1981